Production (Stage)
Ultralife Corporation
ULBI
$5.46
-$0.07-1.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 50.75M | 43.85M | 35.69M | 42.98M | 41.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.75M | 43.85M | 35.69M | 42.98M | 41.93M |
| Cost of Revenue | 38.00M | 33.25M | 27.01M | 31.42M | 30.46M |
| Gross Profit | 12.75M | 10.60M | 8.68M | 11.56M | 11.47M |
| SG&A Expenses | 6.82M | 6.96M | 5.82M | 5.65M | 5.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.22M | 42.63M | 34.93M | 39.07M | 37.86M |
| Operating Income | 3.52M | 1.22M | 761.00K | 3.92M | 4.06M |
| Income Before Tax | 2.45M | 495.00K | 353.00K | 3.85M | 3.61M |
| Income Tax Expenses | 567.00K | 262.00K | 74.00K | 853.00K | 703.00K |
| Earnings from Continuing Operations | 1.88M | 233.00K | 279.00K | 2.99M | 2.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.00K | -39.00K | -21.00K | -24.00K | -13.00K |
| Net Income | 1.87M | 194.00K | 258.00K | 2.97M | 2.89M |
| EBIT | 3.52M | 1.22M | 761.00K | 3.92M | 4.06M |
| EBITDA | 4.88M | 2.40M | 1.76M | 4.93M | 5.03M |
| EPS Basic | 0.11 | 0.01 | 0.02 | 0.18 | 0.18 |
| Normalized Basic EPS | 0.10 | 0.01 | 0.02 | 0.14 | 0.14 |
| EPS Diluted | 0.11 | 0.01 | 0.02 | 0.18 | 0.18 |
| Normalized Diluted EPS | 0.10 | 0.01 | 0.02 | 0.14 | 0.14 |
| Average Basic Shares Outstanding | 16.63M | 16.63M | 16.63M | 16.57M | 16.40M |
| Average Diluted Shares Outstanding | 16.68M | 16.76M | 16.87M | 16.83M | 16.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |